Bioo Scientific has been invited to be a guest of The University of Texas at Austin for the UT Gyeonggi Innovation Program which is being sponsored by Governor Kim Moon-Soo, of the Gyeonggi Province, Korea. The UT Gyeonggi Innovation Program is a 3-year program to promote entrepreneurship, identify promising technology start-up companies and introduce them […]
Los Alamos, New Mexico — Los Alamos National Laboratory successfully completed a Cooperative Research and Development Agreement (CRADA) with Biomagnetics Diagnostics, Inc., in June 2011. The CRADA followed the licensing to Biomagnetics of a LANL-developed prototype waveguide-based optical biosensor — an instrument designed to help in the detection of biological molecules associated with disease using […]
Miraculins Inc. (TSX-V:MOM), a medical diagnostic company focused on developing and commercializing diagnostic tests and risk assessment tools for unmet clinical needs is pleased to announce that it has completed an Exclusive Manufacturing and Supply Agreement with Thermo Fisher Scientific Inc., the world leader in serving science. Under the agreement, Thermo Fisher will supply the […]
CARLSBAD, Calif. — Life Technologies Corporation (NASDAQ:LIFE) today announced that the company has signed an agreement with Quidel Corporation to distribute and commercialize molecular diagnostic assays for the European market. The deal represents Life’s continued growth into the diagnostics space. “About ten percent of Life Technologies’ current revenues derive from molecular diagnostics,” said Kim Caple, […]
MANSFIELD, Mass. — PrimeraDx today announced that Albert Luderer has been appointed to its Board of Directors. President and CEO Matthew McManus commented: “We are excited to have Al join our board at this pivotal time. We have just launched the ICEPlex System, which is the first molecular diagnostics system that is capable of high […]
DENVER–Accelr8 Technology Corporation (NYSE Amex: AXK) announced that Accelr8 and SCHOTT Technical Glass Solutions, GmbH (Jena, Germany) have renewed Accelr8’s license to SCHOTT for Nexterion® microarraying slides using OptiChem® biocoatings. In addition to renewing the existing non-exclusive license, Accelr8 also granted to SCHOTT the right to sell OptiChem®-coated products for application in medical diagnostics. Previously, […]
CAMBRIDGE, Mass. — IntelligentMDx (IMDx) announced today that it has received CE-Mark for its second automated molecular test for the Abbott FDA cleared m2000 instrument. The IMDx™ VanR for Abbott m2000™ test accurately detects and distinguishes the vanA and vanB genes most commonly found in vancomycin-resistant enterococci (VRE) in specimens from patients at risk for […]
MUNICH — Definiens, the leading Health Image Intelligence™ company, announces that it will release a new generation of products at the International Definiens Symposium at the Moffitt Cancer Center in Tampa, FL on October 17–18. The annual symposium is the premier forum for Definiens users and developers from around the world to present the latest […]
Gaithersburg, Maryland and SEOUL, Korea – Seegene today announced the commercialization of its first real-time assay based upon its new TOCE technology. The Anyplex™II STI-7 Detection Assay will provide clinicians with a powerful new tool to help protect health and prevent the spread of sexually transmitted infections (STIs), also known as sexually transmitted diseases (STDs). […]
TURKU, Finland–PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the opening of the world’s largest centralized laboratory for newborn screening, in support of The Egyptian Ministry of Health and Population (MOHP). PerkinElmer, together with its distribution partner HVD Vertriebs GMBH, built the Cairo-based laboratory […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
